Refining the structure and content of clinical genomic reports

To effectively articulate the results of exome and genome sequencing we refined the structure and content of molecular test reports. To communicate results of a randomized control trial aimed at the evaluation of exome sequencing for clinical medicine, we developed a structured narrative report. With feedback from genetics and non‐genetics professionals, we developed separate indication‐specific and incidental findings reports. Standard test report elements were supplemented with research study‐specific language, which highlighted the limitations of exome sequencing and provided detailed, structured results, and interpretations. The report format we developed to communicate research results can easily be transformed for clinical use by removal of research‐specific statements and disclaimers. The development of clinical reports for exome sequencing has shown that accurate and open communication between the clinician and laboratory is ideally an ongoing process to address the increasing complexity of molecular genetic testing. © 2014 Wiley Periodicals, Inc.

[1]  Robert C. Green,et al.  Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium , 2013, Genetics in Medicine.

[2]  Ira M Lubin,et al.  A report template for molecular genetic tests designed to improve communication between the clinician and laboratory. , 2012, Genetic testing and molecular biomarkers.

[3]  Michael S. Watson,et al.  American College of Medical Genetics STANDARDS AND GUIDELINES FOR CLINICAL GENETICS LABORATORIES , 2011 .

[4]  Elaine Lyon,et al.  Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. , 2009, The Journal of molecular diagnostics : JMD.

[5]  M. Gulley,et al.  Clinical laboratory reports in molecular pathology. , 2007, Archives of pathology & laboratory medicine.

[6]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[7]  Bin Chen,et al.  Good laboratory practices for molecular genetic testing for heritable diseases and conditions. , 2009 .

[8]  Emily H Turner,et al.  Actionable, pathogenic incidental findings in 1,000 participants' exomes. , 2013, American journal of human genetics.

[9]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.

[10]  W. Grody,et al.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.

[11]  Matthew S. Lebo,et al.  A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record , 2013, Genetics in Medicine.

[12]  Ira M. Lubin,et al.  Effective communication of molecular genetic test results to primary care providers , 2012, Genetics in Medicine.